Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Karlin

Showing results (191-200 of 195) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 195 results.
Clinical Therapeutics|May 4, 2010
Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: a Phase III, open-label, international multicenter studyMichael Marberger, Amir V Kaisary, Neal D Shore, et al.
Molecular Genetics and Metabolism|September 15, 2009
Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and IIRaymond Y Wang, Elizabeth Jane Cambray-Forker, Kirk Ohanian, et al.
Mayo Clinic Proceedings|August 4, 2012
Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitusIrwin Goldstein, LeRoy A Jones, Laurence H Belkoff, et al.
American Journal of Epidemiology|December 1, 1982
Association arrays for the study of familial height, weight, lipid, and lipoprotein similarity in three West Coast populationsS Karlin, P T Williams, J W Farquhar, et al.
Urology|November 16, 2005
Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastasesThomas J Polascik, Robert W Given, Charles Metzger, et al.
Pageof 20

Showing results (191-200 of 195) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 195 results.
Clinical Therapeutics|May 4, 2010
Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: a Phase III, open-label, international multicenter studyMichael Marberger, Amir V Kaisary, Neal D Shore, et al.
Molecular Genetics and Metabolism|September 15, 2009
Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and IIRaymond Y Wang, Elizabeth Jane Cambray-Forker, Kirk Ohanian, et al.
Mayo Clinic Proceedings|August 4, 2012
Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitusIrwin Goldstein, LeRoy A Jones, Laurence H Belkoff, et al.
American Journal of Epidemiology|December 1, 1982
Association arrays for the study of familial height, weight, lipid, and lipoprotein similarity in three West Coast populationsS Karlin, P T Williams, J W Farquhar, et al.
Urology|November 16, 2005
Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastasesThomas J Polascik, Robert W Given, Charles Metzger, et al.
Pageof 20